Best of ASTRO® 2024: GI Update – Dr. Jelena Lukovic
OR
Chair
Dr. Paris-Ann Ingledew
Dr. Joanne Alfieri
Speaker
Dr. Jelena Lukovic
Studies/trials discussed:
- Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma: A Randomized Phase II Clinical Trial
- Pembrolizumab, radiotherapy, and chemotherapy in neoadjuvant treatment of malignant esophago-gastric diseases (PROCEED): Assessment of survival and patterns of recurrence in a prospective, phase II single-arm trial.
- Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
- Phase I trial of single-photon emission computed tomography–guided liver-directed radiotherapy for patients with low functional liver volume
- Risk of Sexual Dysfunction in Men Treated with Pelvic Radiation Therapy for Locally Advanced Rectal Cancer: 20 Years of Experience with 451 Patients
- Long-Term Anorectal Function in Rectal Cancer Patients Managed by a Watch-andWait Strategy after Neoadjuvant Therapy: A Cross-Sectional Study
